Dr. Spiera is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1088 Park Avenue
New York, NY 10128Phone+1 212-860-2100Fax+1 212-722-7365
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Rheumatology, 1992 - 1995
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1989 - 1992
- Yale School of MedicineClass of 1989
- Columbia CollegeB.A., Summa Cum Laude, 1981 - 1985
Certifications & Licensure![](https://directory.doximity.com/assets/icons/icon-help-e9f0b148a1e6d1f037dde9f26f025c36bd7c99fd4fe31fd76792996fa2aa5e66.svg)
- NY State Medical License 1991 - 2027
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- New York Magazine: Top Doctors Castle Connolly, 2013-2014
- Top Doctors: New York Metro Area Castle Connolly, 2002-2014
- Rheumatology Teacher of the Year 2006
- Join now to see all
Clinical Trials
- Imatinib Mesylate (Gleevec) in the Treatment of Systemic Sclerosis Start of enrollment: 2007 Aug 01
- American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification Criteria for Primary Systemic Vasculitis Start of enrollment: 2011 Jan 01
- Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH) Start of enrollment: 2011 Jun 24
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsAltered X-chromosome inactivation of the TLR7/8 locus and heterogeneity of pDCs in systemic sclerosis.Yong Du, Bérénice Faz-Lopez, Marie Dominique Ah Kioon, Claire Cenac, Michael Pierides
The Journal of Experimental Medicine. 2025-03-03 - Efficacy, Safety, Pharmacokinetics, and Immunogenicity of ABBV-154 in Adults With Glucocorticoid-Dependent Polymyalgia Rheumatica: A Phase 2, Randomized, Double-Blind,...Robert F Spiera, Valerie Devauchelle-Pensec, Claire E Owen, Federico Díaz-González, Tsutomu Takeuchi
Arthritis & Rheumatology. 2025-01-27 - Patient perspectives on educational needs in scleroderma-interstitial lung disease.Tina M Savvaides, Thomas A Di Vitantonio, Armani Edgar, Ronan O'Beirne, Jamuna K Krishnan
Journal of Scleroderma and Related Disorders. 2025-01-06
Journal Articles
- The Scleroderma Patient-Centered Intervention Network Cohort: Baseline Clinical Features and Comparison with Other Large Scleroderma CohortsDaniel E Furst, Robert Spiera, Maureen D Mayes, Lorinda Chung, Suzanne Kafaja, Virginia Steen, Shervin Assassi, Monique Hinchcliff, Rheumatology
- Myeloablative Autologous Stem-Cell Transplantation for Severe SclerodermaSullivan KM, Goldmuntz EA, Keyes-Elstein L, McSweeney PA, Pinckney A, Welch B, Mayes MD, Nash RA, Crofford LJ, Eggleston B, Castina S, Griffith LM, Goldstein JS, Walla..., N Engl J Med, 1/4/2018
- A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Takayasu ArteritisLangford CA, Cuthbertson D, Ytterberg SR, Khalidi N, Monach PA, Carette S, Seo P, Moreland LW, Weisman M, Koening CL, Sreih AG, Spiera R, McAlear CA, Warrington KJ, Pa..., Arthritis Rheumatol, 1/30/2017
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Outcome Measures in Giant Cell Arteritis and Polymyalgia RheumaticaSpiera RF, Fourth International Symposium on Giant Cell Arteritis & Polymyalgia Rheumatica, 1/1/2008
- Extraintestinal Manifestations of Inflammatory Bowel DiseaseSpiera RF, American College of Gastroenterology, 1/1/2001
- Ticlopidine Induced SLE: A Report of Four CasesSpiera RF, ACR National Meeting, 1/1/2000
- Join now to see all
Lectures
- VasculitisMultiple locations, 2002, 2003, 2004, 2007, 2015, 2016 - 1/1/2016
- Temporal ArteritisMultiple locations, 2000, 2001, 2009, 2013, 2014 - 1/1/2014
- Participating in Research-How it Works & What is out ThereNew York, NY - 1/1/2014
- Join now to see all
Authored Content
- Sarilumab in Patients with Relapsing Polymyalgia Rheumatica: A Phase 3, Multicenter, Randomized, Double Blind, Placebo Controlled Trial (SAPHYR)November 2022
- Arterial Lesions in Giant Cell Arteritis: A Longitudinal StudyMay 2018
- Arterial Lesions in Giant Cell Arteritis: A Longitudinal StudyMay 2018
- Arterial Lesions in Giant Cell Arteritis: A Longitudinal StudyMay 2018
- Join now to see all
Press Mentions
- Antibody-Drug Conjugate Tackles Glucocorticoid Use in Polymyalgia RheumaticaFebruary 4th, 2025
- Baricitinib Shows Promise in Polymyalgia RheumaticaJanuary 22nd, 2025
- Study Shows Avacopan Effective for Most Serious Vasculitis CasesNovember 18th, 2024
- Join now to see all
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: